Supernus Pharmaceuticals | SUPN - Eps Gewinn Pro Aktie

Aktienkurs
49.77
Täglich Wechseln
-1.05 -2.07%
Monatlich
-0.86%
Jährlich
54.18%
Q1 Prognose
48.40

Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2026Q1 Mar/2026 0.52 -0.21 May/12 2026
FY2025Q4 Dec/2025 -0.07 0.41 0.27 Feb/24 2026
FY2025Q3 Sep/2025 -0.80 0.37 0.69 Nov/04 2025
FY2025Q2 Jun/2025 0.40 0.46 0.77 Aug/05 2025
FY2025Q1 Mar/2025 -0.21 0.37 0.26 May/06 2025




Eps Veränderung Datum
Abbott USD 1.5 0.2 2025-12
ANI Pharmaceuticals USD 2.33 0.29 2025-12
Aurora Cannabis CAD -1 0.73 2025-09
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Canopy Growth CAD -0.08 0.14 2025-09
Cara Therapeutics USD -5.04 3.24 2024-12
Corcept Therapeutics USD 0.2 0.04 2025-12
Eisai JPY 60.94 24.92 2025-12
Eli Lilly USD 7.54 0.52 2025-12
Novo Nordisk DKK 6.04 1.54 2025-12
Pacira USD 0.06 0.64 2025-12
Perrigo USD 0.77 0.03 2025-12
Pfizer USD 0.66 0.21 2025-12
Supernus Pharmaceuticals USD -0.07 0.73 2025-12
United Therapeutics USD 7.7 0.54 2025-12
Xeris Pharmaceuticals USD 0 0.02 2025-09